Abstract
C2 domains regulate numerous eukaryotic signaling proteins by docking to target membranes upon binding Ca2+. Effective activation of the C2 domain by intracellular Ca2+ signals requires high Ca2+ selectivity to exclude the prevalent physiological metal ions K+, Na+, and Mg2+. The cooperative binding of two Ca2+ ions to the C2 domain of cytosolic phospholipase A2 (cPLA2-α) induces docking to phosphatidylcholine (PC) membranes. The ionic charge and size selectivities of this C2 domain were probed with representative mono-, di-, and trivalent spherical metal cations. Physiological concentrations of monovalent cations and Mg2+ failed to bind to the domain and to induce docking to PC membranes. Superphysiological concentrations of Mg2+ did bind but still failed to induce membrane docking. In contrast, Ca2+, Sr2+, and Ba2+ bound to the domain in the low micromolar range, induced electrophoretic mobility shifts in native polyacrylamide gels, stabilized the domain against thermal denaturation, and induced docking to PC membranes. In the absence of membranes, the degree of apparent positive cooperativity in binding of Ca2+, Sr2+, and Ba2+ decreased with increasing cation size, suggesting that the C2 domain binds two Ca2+ or Sr2+ ions, but only one Ba2+ ion. These stoichiometries were correlated with the abilities of the ions to drive membrane docking, such that micromolar concentrations of Ca2+ and Sr2+ triggered docking while even millimolar concentrations of Ba2+ yielded poor docking efficiency. The simplest explanation is that two bound divalent cations are required for stable membrane association. The physiological Ca2+ ion triggered membrane docking at 20-fold lower concentrations than Sr2+, due to both the higher Ca2+ affinity of the free domain and the higher affinity of the Ca2+-loaded domain for membranes. Kinetic studies indicated that Ca2+ ions bound to the free domain are retained at least 5-fold longer than Sr2+ ions. Moreover, the Ca2+-loaded domain remained bound to membranes 2-fold longer than the Sr2+- loaded domain. For both Ca2+ and Sr2+, the two bound metal ions dissociate from the protein–membrane complex in two kinetically resolvable steps. Finally, representative trivalent lanthanide ions bound to the domain with high affinity and positive cooperativity, and induced docking to PC membranes. Overall, the results demonstrate that both cation charge and size constraints contribute to the high Ca2+ selectivity of the C2 domain and suggest that formation of a cPLA2-α C2 domain–membrane complex requires two bound multivalent metal ions. These features are proposed to stem from the unique structural features of the metal ion-binding site in the C2 domain.
The C2 domain is a eukaryotic membrane-targeting protein module present in numerous signal transducing proteins that carry out key cellular functions at membranes (reviewed in refs 1 and 2). These processes include the generation of lipid second messengers, vesicular transport, GTPase regulation, protein phosphorylation, pore formation by cytolytic T cells, and ubiquitin-mediated protein degradation. C2 domains bind a variety of cellular targets, including phospholipids, inositol polyphosphates, and other membrane-associated proteins (1, 2). Many of these C2 domains bind to target membranes in response to the micromolar Ca2+ levels generated during intracellular Ca2+ fluxes. The structures of representative Ca2+-regulated C2 domains, including the C2A domain of synaptotagmin I (Syt-IA),1 the C2 domain of cytosolic phospholipase A2 (α-isoform, cPLA2-α), and the C2 domain of protein kinase C (β-isoform, PKC-β), have been determined by X-ray crystallography and NMR spectroscopy (3–8). These C2 domains are divided into two distinct topological classes (1), both of which are constructed of β-sandwich architecture. At one edge of the β-sandwich, two or more Ca2+ ions bind in an aspartate-lined cleft formed by three interstrand loops. Equilibrium Ca2+ binding measurements have shown that the isolated cPLA2-α C2 domain binds two Ca2+ ions with low micromolar affinity when free in solution, and with even higher affinity when bound to target phosphatidylcholine (PC) membranes (7, 9). Two Ca2+ ions have also been observed in the crystal structure of the domain (6, 8). The binding of the Ca2+ ions is positively cooperative and induces docking of the domain to phosphatidylcholine (PC) membranes (9–11) such that that the C2 domain is activated over the narrow micromolar range of Ca2+ concentrations achieved during intracellular Ca2+ signaling. In contrast, three Ca2+ ions bind to the Syt-IA and PKC-β C2 domains and induce docking to anionic lipids such as phosphatidylserine (PS). It has become clear that C2 domains exhibit different modes of membrane binding and Ca2+ activation parameters adapted for distinct signaling pathways (12).
C2 domains regulated by micromolar cytoplasmic Ca2+ signals must possess the ability to selectively bind Ca2+ in the presence of 103–104-fold higher concentrations of K+, Na+, and Mg2+ (13). Several studies have indicated that physiological levels of these background cations do not induce binding of Ca2+-dependent C2 domains to target membranes (11, 14, 15), although a sub-millimolar Mg2+ concentration induces membrane binding by the C2A domain of synaptotagmin III (15). In addition, spherical divalent cations other than Ca2+ induce membrane docking by various C2 domains (14–17), including cPLA2-α (11). In general, the potency of these cations follows this order: Ca2+ > Sr2+ > Ba2+ ≫ Mg2+. This order of potency also reflects the ability of these ions to promote enzymatic activity of cPLA2-α (18). It is not clear, however, whether this cation specificity stems primarily from the metal affinity of the free C2 domain or from the stability of different domain–metal–membrane complexes. In principle, the target membrane could contribute to the observed cation specificity of C2 domains, since (i) target membranes significantly increase the Ca2+ affinity of the cPLA2-α, Syt-IA, and PKC-β C2 domains (12, 19), (ii) the membrane surface contacts the Ca2+-binding loops of the C2 domain when docked to target membranes (reviewed in ref 12), (iii) phospholipid membranes bind divalent cations with selectivity (20), and (iv) phospholipid may complete the coordination shell surrounding the exposed bound Ca2+ by displacing coordinating water molecules as observed for the C2 domain of PKC-α (21). Thus, a complete understanding of the molecular basis of the Ca2+ selectivity of the C2 domain requires the evaluation of metal ion binding by the C2 domain in both its membrane-free and -bound states.
This study probed the Ca2+-binding site of the cPLA2-α C2 domain to better define its cation charge and size selectivity. The Ca2+-activated C2 domain is responsible for targeting cPLA2-α to cytoplasmic membranes (22–24), where its Ca2+-independent catalytic domain liberates arachidonic acid from glycerophospholipids to initiate eicosanoid pathways, including inflammation (25–27). When Ca2+ binds, the intrinsic tryptophan fluorescence of the cPLA2-α C2 domain increases due to structural, electrostatic, or dynamic changes that influence the environment of the sole tryptophan (Trp71) partially buried in the domain (9, 12). This fluorescence increase enables evaluation of the equilibrium and kinetic binding parameters of various metal ions for the cPLA2-α C2 domain in the presence and absence of target membranes. The results presented here demonstrate that spherical monovalent cations and Mg2+ are virtually excluded from the site at physiological concentrations, in the absence or presence of target membranes. In contrast, spherical divalent cations (larger than Mg2+) and trivalent cations bind to the site, even in the absence of membranes, and induce membrane docking by the domain. A relationship is observed between the ionic radius and the apparent stoichiometry of divalent cation binding to the isolated C2 domain, as revealed by the Hill coefficient of positive cooperativity. Furthermore, the degree of positive cooperativity is related to the ability of the divalent cation to induce membrane docking, suggesting that the binding of two metal ions is required to induce membrane docking. A model for the formation of a C2 domain–Ca2+–phospholipid complex is discussed.
MATERIALS AND METHODS
Reagents
Chloride salts (>99.5% pure) of mono-, di-, and trivalent metal ions were used (Aldrich or Fluka). According to the manufacturer’s specifications, MgCl2 contained <0.001% Ca2+. The PC that was utilized was 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids). The dansyl-PE that was utilized was N-[5-(dimethylamino)- naphthalene-1-sulfonyl]-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (Molecular Probes).
C2 Domain Production and Isolation
The cPLA2-α C2 domain, spanning the first 138 residues of the human enzyme, was expressed in Escherichia coli inclusion bodies, refolded in vitro, and purified as described previously (9). Active monomers of the refolded C2 domain were purified by Ca2+-dependent binding to a PC–phenyl Sepharose column, elution with ethylenediaminetetraacetic acid (EDTA), and being passed over a Sephadex G-75 gel filtration column. C2 domain preparations were judged to be >90% pure when analyzed by denaturing polyacrylamide gel electrophoresis (PAGE). Protein was snap-frozen in standard buffer composed of 100 mM KCl and 20 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) (pH 7.0) with KOH, supplemented with 1 mM CaCl2, and stored at −80 °C. Protein was decalcified by being passed over Chelex-100 resin prior to use and quantified by the Bradford assay using a C2 domain standard, the concentration of which was determined by the tyrosinate method (28).
Native-PAGE Analysis
The C2 domain was resuspended in standard buffer containing 2 mM EDTA with or without 3 mM divalent cation. Reversibility was tested by chelating divalent cations with an additional 2 mM EDTA after a short incubation. To test the effect of monovalent cations, the C2 domain was resuspended in 20 mM PIPES (pH 7.0) and 2 mM EDTA with or without 200 mM KCl or NaCl. Protein samples were subjected to 15% nondenaturing PAGE and stained with Coomassie Brilliant Blue.
Determination of Tm
The temperature dependence of the intrinsic fluorescence Trp71 of the C2 domain was monitored as a measure of the integrity of domain folding (9) on an SLM 48000S fluorescence spectrometer in thermostated quartz cuvettes (λex = 284 nm, excitation bandwidth = 4 nm, emission bandwidth = 8 nm). Emission of the C2 domain was scanned or monitored at a single wavelength (λem = 325 nm). To test the effect of monovalent cations, the C2 domain (0.5 µM) was incubated in 20 mM PIPES (pH 7.0) and 1 mM EDTA with or without 100–200 mM KCl or NaCl. To test divalent cations, the C2 domain was incubated in standard buffer containing 1 mM EDTA and 2 mM divalent cations. The temperature was increased step-wise, allowing the protein to equilibrate 30 min at each temperature before fluorescence was measured. The fraction of the denatured C2 domain (f) was calculated assuming a two-state (native and denatured) model of the protein as (28):
| (1) |
where F represents the Trp71 emission at 325 nm, T is the temperature, and α + βT and γ + δT are the linear temperature-dependent changes in Trp71 emission in the native and denatured states, respectively, determined by extrapolation. Tm values, where f = 0.5, were calculated as the midpoint of plots of ln[f/(1 − f)] versus temperature in the linear transition region.
Fluorescence Detection of Cation and Membrane Binding
The intrinsic Trp71 fluorescence of the C2 domain (0.5 µM), without or with sonicated vesicles of PC (100 µM), was monitored at 25 °C in standard buffer as described previously (9). Buffer-subtracted emission spectra were recorded for samples diluted in standard buffer to which 1 mM CaCl2 and 5 mM EDTA had been sequentially added.
The cation dependence of the fluorescence increase was quantified by monitoring the fluorescence emission (λem = 325 nm) upon addition of concentrated solutions of cations to the C2 domain in standard buffer. The fluorescence change (ΔF) was plotted as a function of free cation concentration (x) and best-fitted using a modified Hill equation:
| (2) |
where ΔFmax represents the calculated maximal fluorescence change, H represents the Hill coefficient, and [cation]1/2 represents the free cation concentration that induces a halfmaximal fluorescence change. ΔFmax was normalized to the initial fluorescence intensity of the C2 domain prior to addition of cation (F0) and expressed as a percentage to compare the relative fluorescence changes induced by saturating amounts of different cations. The reversibility of the cation-induced fluorescence change was demonstrated by addition of excess EDTA upon completion of the titration. Since ΔF did not plateau by 10 mM Mg2+ (see Figure 2A), a relative ΔFmax of 13% was used for normalization in Mg2+ titrations.
C2 domain binding to sonicated vesicles of PC was assessed using fluorescence resonance energy transfer (FRET) as described previously (9, 29). Trp71 of the C2 domain was used as a fluorescence donor, and dansyl-PE incorporated into PC vesicles was used as the fluorescence acceptor. FRET was assessed by mixing the C2 domain (0.5 µM) at 25 °C in standard buffer with vesicles of PC containing a small mole fraction of dansyl-PE (PC:dPE lipid mole ratio of 95:5, total lipid concentration of 100 µM). The C2 domain was excited, and fluorescence emission of dansyl-PE was monitored (λex = 284 nm; λem = 520 nm). The change in the FRET signal was analyzed by the Hill equation (eq 2). The reversibility of FRET was demonstrated by addition of excess EDTA at the completion of the titration. Since ΔF did not approach a plateau in Ba2+ and Mg2+ titrations (see Figure 4A), relative ΔFmax values from Ca2+ titrations were used for normalization.
Application of the Hill equation to this analysis of fluorescent data is an approximation, first, since the Hill approach was designed to examine the stoichiometric binding of ligands to multiple identical binding sites and, second, since in this case the relative fluorescence changes for multiple binding events is not known. Nevertheless, Hill analysis can offer insight into the binding mechanism by providing an accurate determination of the [cation]1/2 value, the concentration of cation that elicits a half-maximal fluorescence change, which is related to the binding affinity. Moreover, an observed Hill coefficient of >1.4 (and <2) indicates positive cooperativity in cation binding, even when the fluorescence changes that accompany binding of the individual ions are unknown, and thus a stoichiometry of at least two ions (30).
The phospholipid dependence of FRET was quantified as described previously (9) by mixing the C2 domain (0.5 µM) at 25 °C with 1 mM EDTA and 2 mM divalent cations in standard buffer and monitoring the emission of dansyl-PE upon addition of concentrated stocks of PC vesicles containing dansyl-PE (5% mol/mol). The change in FRET signal (ΔF) due to C2 domain binding was plotted as a function of PC concentration (x) and best-fitted using the equation for a single population of identical sites:
| (3) |
where represents the apparent equilibrium dissociation constant of the C2 domain for PC in the presence of approximately 1 mM free divalent cation. In these experiments, the concentration of the C2 domain was small compared to the calculated ; thus, the total concentration of PC was taken as the free concentration. Since ΔF did not approach a plateau during Ba2+ and Mg2+ titrations (see Figure 4B), relative ΔFmax values from Ca2+ titrations were used for normalization.
For all equilibrium fluorescence experiments, buffers, plasticware, and quartz cuvettes were decalcified prior to use as described previously (31). Using these procedures, levels of Ca2+ contamination in the sample solutions were estimated to be no more than 0.3 µM in equilibrium fluorescence experiments (data not shown), as determined by the fluorescent Ca2+ chelator Quin-2. In experiments in which the properties of the C2 domain in the presence of PC vesicles and Ca2+ at pH 7.0 were monitored, total Ca2+ levels required only small corrections for both Ca2+ contamination and the small fraction of the Ca2+ population bound to the C2 domain (assuming a stoichiometry of two ions per domain) to obtain free Ca2+ levels at each step in the titration. Previously, little or no binding of Ca2+ to PC vesicles (2 mM) was demonstrated by equilibrium dialysis (9), obviating corrections for Ca2+ binding to the membranes themselves. Because of the lower affinities of the other divalent cations, total ion levels were taken as free levels. Assays testing the binding of trivalent cations were carried out in 100 mM KCl and 20 mM PIPES (pH 6.0) (see the Results).
Large Phospholipid Vesicle Binding Assay
C2 domain binding to large multilamellar phospholipid vesicles was assessed as described previously (11). Briefly, the C2 domain in standard buffer containing 1 mM EDTA and 2 mM divalent cations was incubated in suspensions of pure PC membranes prepared by brief sonication. Unbound C2 domain was separated from membrane-bound material by centrifugation. Bound and unbound fractions were subjected to SDS–PAGE, stained with Coomassie Brilliant Blue, and quantified by densitometry. The amount of C2 domain bound to phospholipid was calculated as the percentage of total supernatant and pellet C2 domain present in pellet fractions.
Stopped-Flow Fluorescence Spectroscopy
Stopped-flow fluorescence spectroscopy was carried out on an Applied Photophysics model 17 MV stopped-flow spectrofluorometer in standard buffer at 25 °C as described previously (9). The dead time of the instrument was determined to be ~1.5 ms (32); hence, data collected during the first 1.5 ms were omitted from analysis. To measure the time course of Trp71 changes in the C2 domain upon cation dissociation, the C2 domain (5 µM), diluted in 100 µM divalent cation with or without vesicles of PC (250 µM), was rapidly mixed with 5 mM EDTA. The intrinsic fluorescence of Trp71 in the C2 domain was recorded using a λex of 284 nm and a 335 nm high-pass filter. To measure the time course of FRET between the C2 domain and membranes, the C2 domain (5 µM), diluted in 100 µM divalent cation with vesicles (250 µM total lipid composed of a 95:5 PC/dPE mixture), was rapidly mixed with 5 mM EDTA; the fluorescence of dansyl-PE was recorded using a λex of 284 nm and a 475 nm high-pass filter. Four thousand data points were collected over 0.1 s for rapid time courses and over 5 s for slow time courses. The fluorescence (F) was plotted as a function of time (t) and was best-fitted by equations for mono- or biexponential decay processes as described previously (9). The monoexponential decay process is given by
| (4) |
where k is the rate constant of the event monitored, ΔF is the fluorescence amplitude, and C is the intrinsic voltage offset of the stopped-flow experiment. The biexponential sequential decay process is described by
| (5) |
where k1 and k2 are the rate constants of the first- and second-order events, respectively, and ΔF1 and ΔF2 are the fluorescence amplitudes of these steps, respectively. Experiments in which Quin-2 was used to monitor cation release from the C2 domain were carried out as previously described (9).
RESULTS
Strategy
The cPL-A2-α C2 domain binds two Ca2+ ions and forms a kinetically stable complex with PC membranes in vitro at physiological concentrations of Ca2+ (9). In EDTA buffering systems that maintain known free cation concentrations, the cPLA2-α C2 domain prefers Ca2+ over other group IIA cations for the induction of membrane docking (11), a property displayed by other C2 domains (14–17). The study presented here probed the Ca2+-binding site of the C2 domain with monovalent group IA, divalent group IIA, and representative trivalent cations to better define its charge and size selectivity in both the absence and presence of target membranes. All of these cations possess filled outer electronic subshells and thus can be treated as simple hard spheres whose optimal coordination is defined by ligand packing constraints, rather than by a preferred coordination geometry (33). Due to the tendency of trivalent lanthanide ions to form insoluble hydroxide complexes, experiments with lanthanide ions were carried out at a lower pH (6.0 compared to 7.0, which was used for other cations) and are discussed separately at the end of the Results.
Effects of Cations on the Electrophoretic Mobility and Stability of the Free Domain
Binding of Ca2+ to the free cPLA2-α C2 domain quantitatively shifted its electrophoretic mobility in native PAGE (data not shown and refs 9 and 24). The shift induced by Ca2+ retarded the migration of the anionic C2 domain toward the positive electrode. When excess EDTA was added to the sample prior to electrophoresis, the mobility shifted back to approximately that of the C2 domain incubated with EDTA alone. Both Sr2+ and Ba2+ induced a comparable mobility shift, whereas Mg2+ and 200 mM KCl and NaCl failed to induce this mobility shift (data not shown). These results indicate that the binding of Ca2+, Sr2+, and Ba2+ alters the size, shape, or charge of the cPLA2-α C2 domain, whereas the binding of Mg2+, K+, or Na+ cannot be detected by this assay.
The level of stabilization of the free cPLA2-α C2 domain by the binding of cations was measured as an increase in the melting temperature (Tm) of the C2 domain upon addition of 1 mM free divalent cation (Figure 1). The Tm for thermal denaturation was determined by monitoring the intrinsic fluorescence of Trp71 in the cPLA2-α C2 domain, which red shifts and is partially quenched when the domain unfolds in the presence of chemical denaturants (11) or at increased temperatures (Figure 1A). Thermal denaturation curves were analyzed using eq 1, assuming a two-state model in which a unique native state is converted to a single unfolded state (Figure 1B). The average Tm (±SEM, n = 3) of the C2 domain, which was 46.4 ± 0.1 °C in the absence of divalent cations, increased to 64.9 ± 0.7 °C in the presence of Ca2+. Similar Tm values and increases in Tm by Ca2+ binding have been reported for the C2A domain of synaptotagmin I using circular dichroism (34). Ca2+ binding has also been shown to increase the Tm of the PKC-α C2 domain measured by Fourier transform infrared spectroscopy (35). Sr2+ and Ba2+ increased the Tm of the C2 domain to 56.7 ± 0.6 and 58.0 ± 0.5 °C, respectively, whereas Mg2+ had no effect (Tm = 46.1 ± 0.2 °C). In addition, 200 mM K+ or Na+ had no effect on Tm (data not shown). These results indicate that the binding of Ca2+, Sr2+, or Ba2+ stabilizes the folded C2 domain against thermal denaturation, while the binding of Mg2+, K+, and Na+ was not detected by this assay. The greater enhancement in Tm induced by Ca2+ over Sr2+ and Ba2+ is likely to indicate a higher affinity of Ca2+ at elevated temperatures or a greater intrinsic stability of the Ca2+-occupied state.
Figure 1.
Group IIA cations stabilize the cPLA2-α C2 domain against thermal denaturation. (A) Buffer-subtracted intrinsic emission spectra of the C2 domain without added divalent cation, recorded at ~5 °C intervals between 25 and 80 °C. (B) Thermal unfolding of the C2 domain measured by monitoring Trp71 emission (λem = 325 nm) in the presence of no added divalent cation [none (□)] or one of the following: 2 mM total Mg2+ (○), Ca2+ (●), Sr2+ (■), or Ba2+ (▲). Tm values were calculated at the midpoints of the linear transitions (see Materials and Methods), and 200 mM Na+ and K+ had no effect on Tm values (data not shown). Experimental conditions for both panels A and B: 100 mM KCl, 20 mM PIPES, pH 7.0, and 1 mM EDTA (λex = 284 nm).
Cation-Induced Intrinsic Fluorescence Changes in the Absence and Presence of Membranes
The ability of Ca2+ to bind to the cPLA2-α C2 domain, in both the absence and presence of target membranes, was measured using the intrinsic Trp71 of the domain as a probe. The Ca2+ dependencies of the intrinsic Trp71 changes were previously demonstrated to be strikingly similar to the binding of Ca2+ assessed directly by equilibrium dialysis, suggesting that the environmental changes detected by Trp71 are directly coupled to the cooperative binding of two Ca2+ ions (9). As observed previously (9, 12, 36), Ca2+ induced an increase in Trp71 fluorescence, which was reversed upon chelation of Ca2+ by addition of excess EDTA. In the presence of PC vesicles, Ca2+ elicited an even greater increase in Trp71 fluorescence, which was also reversed by EDTA addition. Thus, both Ca2+ binding and membrane docking induce changes in the domain that alter the environment of Trp71. Addition of up to 100 mM Na+ or 200 mM K+ failed to significantly alter Trp71 fluorescence in the absence or presence of vesicles (data not shown), demonstrating that physiological concentrations of these monovalent cations do not cause detectable environmental changes at this location.
The same assay was used to quantitatively compare the binding of Ca2+ and other group IIA cations to the cPLA2-α C2 domain, in both the presence and absence of target membranes (Figure 2). The fluorescence changes (ΔF) were plotted against free cation concentration and fitted with the Hill equation (eq 2) to determine [cation]1/2, the concentration of cation that induces a half-maximal fluorescence change, the Hill coefficient (H), a constant related to cation stoichiometry and cooperativity (see Materials and Methods), and ΔFmax (Table 1). In the absence of membranes, Mg2+ at >1 mM increased Trp71 fluorescence, indicating that this small divalent cation can bind to the free C2 domain at superphysiological concentrations; however, the apparent affinity was too low to achieve plateau values even at 10 mM Mg2+. Thus, a lower limit for the [Mg2+]1/2 value was placed at 10 mM. In contrast, Ca2+, Sr2+, and Ba2+ bound to the free C2 domain at much lower concentrations, yielding [cation]1/2 values of 11, 31, and 14 µM, respectively. Ca2+, Sr2+, and Ba2+ induced similar maximal fluorescence increases (normalized ΔFmax = 12–13%). The Hill coefficient decreased as ionic size increased, calculated as 1.8, 1.4, and 1.1 for Ca2+, Sr2+, and Ba2+, respectively. Given that this C2 domain is known to bind only two Ca2+ ions (6, 7, 9), these apparent Hill values strongly suggest that two Ca2+ and Sr2+ ions bind to the free C2 domain in a positively cooperative manner but that only one Ba2+ ion binds to the domain in the micromolar range.
Figure 2.
Group IIA cation binding to the cPLA2-α C2 domain is selective. Intrinsic fluorescence changes in Trp71 of the C2 domain induced by the indicated divalent cations in the absence (white symbols) or presence (black symbols) of PC vesicles (100 µM PC). Fluorescence emission of Trp71 was monitored. The observed fluorescence change (ΔF) was normalized to the calculated maximal cation-induced fluorescence change (ΔFmax). Solid lines represent the fitting to the Hill equation (eq 2), except for Mg2+ titration; equilibrium parameters are summarized in Table 1. Cation-induced increases in intrinsic fluorescence were reversed by addition of excess EDTA at the completion of the titrations (not shown). Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 7.0, and 25 °C (λex = 284 nm; λem = 325 nm).
Table 1.
Equilibrium Parameters for Events Driven by Divalent Cation Binding to the cPLA2-α C2 Domaina
| cation | cation bindingb | cation requirement for membrane bindingc |
membrane bindingd | ||||||
|---|---|---|---|---|---|---|---|---|---|
| without vesicles | with vesicles | ||||||||
| [cation]1/2 (µM) |
Hill coefficient |
normalized ΔFmax (%) |
[cation]1/2 (µM) |
Hill coefficient |
normalized ΔFmax (%) |
[cation]1/2 (µM) |
Hill coefficient |
(µM) | |
| Mg2+ | >10000e | NDf | NDf | >10000e | NDf | NDf | ≫10000g | NDf | ≫100g |
| Ca2+ | 11 ± 2 | 1.8 ± 0.1 | 13 ±1 | 2± 1 | 1.8 ± 0.2 | 25 ±1 | 2± 1 | 1.9 ± 0.2 | 11 ± 1 |
| Sr2+ | 31 ± 2 | 1.4 ± 0.1 | 13 ±1 | 18± 2 | 1.2 ± 0.1 | 22 ±2 | 43± 1 | 1.2 ± 0.1 | 40 ± 3 |
| Ba2+ | 14 ± 2 | 1.0 ± 0.1 | 12 ±1 | 15± 3 | 1.0 ± 0.1 | 12 ± 1 | >2000e | NDf | >170e |
Results are expressed as averages ± SEM (n = 3). Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 7.0, and 25 °C.
Determined by monitoring the intrinsic Trp71 fluorescence of the C2 domain in the absence or presence of PC vesicles (100 µM phospholipid), as described in the legend of Figure 2. Data analyzed by fitting to the Hill equation (eq 2).
Determined by monitoring protein to membrane FRET in the presence of PC/dansyl-PE vesicles (95:5, 100 µM phospholipid), as described in the legend of Figure 4A. Data analyzed by fitting to the Hill equation (eq 2).
Determined by monitoring protein to membrane FRET using PC/dansyl-PE vesicles (95:5), as described in the legend of Figure 4B. Data analyzed by fitting to the independent site equation (eq 3).
The value is a lower limit estimate of the titration midpoint since the observed fluorescence change did not plateau.
Not determined due to insufficient affinity.
No binding observed at this ligand concentration.
In the presence of PC membranes, the [cation]1/2 value decreased for both Ca2+ (to 1.6 µM) and Sr2+ (to 18 µM) but was unchanged for Mg2+ and Ba2+ (Figure 2 and Table 1). In addition, maximal fluorescence changes increased for only Ca2+ and Sr2+ (to 25 and 22%, respectively) but not for Ba2+ (ΔFmax = 12%), suggesting that only Ca2+ and Sr2+ induce membrane docking at low ion concentrations. In the presence of PC membranes, Hill coefficients of 1.8, 1.2, and 1.0 were observed for Ca2+, Sr2+, and Ba2+, respectively; all of these coefficients were similar to their values in the absence of membranes. Together, these results suggest that although the Ca2+-binding site of the cPLA2-α C2 domain can accommodate the larger group IIA cations Ca2+, Sr2+, and Ba2+, only the Ca2+ and Sr2+ ions bind with a stoichiometry of two per domain and trigger membrane docking. By contrast, Ba2+ appears to bind with a stoichiometry of one per domain and fails to drive membrane association.
Cation-Induced Membrane Binding
The ability of group IIA cations to induce the binding of the cPLA2-α C2 domain to target membranes was further tested in a direct centrifugation assay (Figure 3). This assay revealed that Ca2+, and to a lesser extent Sr2+, promotes the binding of the C2 domain to large vesicles of PC. Little or no binding of the C2 domain to PC vesicles was observed in the absence of divalent cations or in the presence of Mg2+ or Ba2+.
Figure 3.
Group IIA cations induce selective binding of the cPLA2-α C2 domain to large vesicles. The C2 domain was incubated with PC vesicles without (none) or with the indicated divalent cation at 2 mM. C2 domain bound to the vesicles was separated from unbound protein by centrifugation. Supernatant and the pelleted vesicle fraction were analyzed by 15% SDS–PAGE and quantified by staining with Coomassie Brilliant Blue. Results are expressed as the fraction of the total protein that is present in the pellet. Bars are averages of three independent determinations; error bars represent standard errors of the mean. Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 7.0, 1 mM EDTA, and room temperature.
The cation selectivity of the cPLA2-α C2 domain for docking to target membranes was measured more quantitatively using a fluorescence resonance energy transfer (FRET) assay (Figure 4). Ca2+-induced membrane docking results in transfer of the donor Trp71 fluorescence from the C2 domain to the acceptor dansyl-PE fluorophore in 95:5 PC/dPE membranes (data not shown). Such FRET requires the proximity of the Trp71 and the dansyl-PE probes that exists during the docking of the C2 domain to membranes [R0 = 21 Å (37)]. The increase in acceptor dansyl-PE emission by FRET was reversed by addition of EDTA, demonstrating the reversibility of the FRET signal upon disruption of the protein–membrane complex by Ca2+ chelation. Addition of up to 200 mM Na+ and K+ (data not shown) and up to 10 mM Mg2+ failed to elicit significant FRET (Figure 4A). These results indicate that physiological concentrations of Ca2+, but not K+, Na+, and Mg2+, induce docking of the C2 domain to target membranes.
Figure 4.
Group IIA cations selectively induce docking of the cPLA2-α C2 domain to PC membranes. (A) Divalent cation dependence of C2 domain docking to PC membranes containing dansyl-PE as assessed by protein to membrane FRET. The observed FRET change (ΔF) was fitted (—) with the Hill equation (eq 2) and normalized to the calculated maximal cation-induced FRET change (ΔFmax); best-fit parameters are summarized in Table 1. Cation-induced FRET signals were reversed by addition of excess EDTA at the completion of the titration (not shown). Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 7.0, 100 µM PC/dansyl-PE (95:5), and 25 °C (λex = 284 nm; λem = 520 nm). (B) Phospholipid dependence of protein to membrane FRET. The FRET change (ΔF) arising from the C2 domain was normalized to the calculated maximal Ca2+-induced FRET change (ΔFmax) and fitted with the single-site equation (eq 3); best-fit parameters are given in Table 1. No concentration-dependent increases in the FRET signal were obtained with the C2 domain without added divalent cation (data not shown). Cation-induced FRET increases were reversed by addition of excess EDTA at the completion of the titrations (not shown). Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 7.0, 2 mM divalent cation, 1 mM EDTA, 95:5 PC/dansyl-PE, and 25 °C (λex = 284 nm; λem = 520 nm).
The concentration-dependent FRET signals elicited by Ca2+, Sr2+, and Ba2+ were fitted with the Hill equation (eq 2) (Figure 4A and Table 1). The [cation]1/2 values of 2.2 and 43 µM were observed for the induction of membrane docking by Ca2+ and Sr2+, respectively (Table 1). These values are very similar, within 2.3-fold, to the corresponding values measured by monitoring Trp71 fluorescence changes, indicating the direct coupling between Ca2+ binding and membrane docking. Furthermore, the Hill coefficients of 1.9 and 1.2 measured by FRET for Ca2+ and Sr2+, respectively, are the same within error as those obtained in the Trp71 fluorescence assay. Notably, the FRET results placed the lower limit for [Ba2+]1/2 at 2 mM, since at this concentration of Ba2+ the binding of the C2 domain to PC membranes was not yet half-complete. These results indicate that divalent cations differ in their ability to induce membrane docking of the C2 domain to target membranes. Ca2+ is 20-fold more potent than Sr2+, at least 1000-fold more potent than Ba2+, and at least 5000-fold more potent than Mg2+. The higher potency of Ca2+ relative to Sr2+ stems from both the higher Ca2+ affinity of the free domain and the higher membrane affinity of the Ca2+-occupied domain (Table 1).
The cation selectivity of the cPLA2-α C2 domain was further investigated by measuring the PC dependence of membrane docking induced by saturating concentrations of divalent cations (Figure 4B and Table 1). This FRET experiment measures the apparent dissociation constant of the cPLA2-α C2 domain for PC () in the presence of 1 mM free group IIA cations (eq 3), a concentration at which the free C2 domain is saturated with divalent cations that induce Trp71 fluorescence changes (see Figure 2). The affinity of the C2 domain for target membranes was greatest in the presence of Ca2+, where the apparent dissociation constant for PC () was 4-fold smaller than in the presence of Sr2+ () and at least 15-fold smaller than in the presence of Ba2+ for which only a lower limit could be measured (). In contrast, at >100 µM PC, no binding of the C2 domain to target membranes was observed in the presence of Mg2+ or in the absence of divalent cations (9). Calculated normalized ΔFmax values were identical for Ca2+ and Sr2+ (data not shown), confirming that the concentrations of Ca2+ and Sr2+ that were used were saturating, able to drive equivalent amounts of the C2 domain onto target vesicles, and that the C2 domain displays higher affinity for PC membranes when loaded with Ca2+ than when loaded with Sr2+. These results further demonstrate that membrane docking by the cPLA2-α C2 domain is preferentially induced by Ca2+ over other group IIA cations and that only Sr2+ exhibits the ability to efficiently replace Ca2+.
Kinetics of Divalent Cation Dissociation
Stopped-flow fluorescence spectroscopy was employed to examine the kinetic parameters responsible for the enhanced affinity of the cPLA2-α C2 domain for Ca2+ over other group IIA cations (Figure 5 and Table 2). In these experiments, a solution containing the C2 domain, in the presence or absence of PC membranes, and 100 µM divalent cation was rapidly mixed by stopped-flow methods with a solution containing excess EDTA to rapidly bind free cations. The decay in the intrinsic Trp71 signal was monitored to measure the environmental changes in the C2 domain that are coupled to irreversible cation dissociation. Previously, we showed that the rate constants for Trp71 fluorescence changes in the domain induced by Ca2+ chelation were very similar, within 1.7-fold, to the rate constants for Ca2+ release directly measured using the fluorescent Ca2+ chelator Quin-2 (9). Thus, monitoring Trp71 emission upon cation chelation with EDTA allows an accurate assessment of an irreversible release of bound cations. In the absence of PC membranes, the time courses of release of group IIA cations from the cPLA2-α C2 domain were best-fitted with monoexponential equations (eq 4). The rate constants for release of Sr2+ and Ba2+ from the free C2 domain (>560 and >630 s−1, respectively) were considerably larger than that for Ca2+ (108 s−1) (Table 2).
Figure 5.
Dissociation kinetics of complexes containing the cPLA2-α C2 domain, divalent cations, and membranes. (A) Kinetics of divalent cation dissociation from the membrane-bound C2 domain complex as measured by stopped-flow fluorescence spectroscopy. Solutions of the C2 domain (5 µM) in Ca2+ or Sr2+ (100 µM) with vesicles of PC (250 µM) were rapidly mixed with 5 mM EDTA. The intrinsic Trp71 fluorescence of the C2 domain was monitored using a λex of 284 nm and a 335 nm high-pass emission filter. The time courses of fluorescence decays were fitted with the ordered-sequential equation (eq 5) and normalized (—). (B) Decay of the protein-to-membrane FRET signal upon divalent cation dissociation. Solutions of the C2 domain (5 µM) in Ca2+ or Sr2+ (100 µM) and PC/dansyl-PE vesicles (95:5; 250 µM) were rapidly mixed with 5 mM EDTA. The fluorescence of dansyl-PE was monitored using a λex of 284 nm and a 475 nm high-pass emission filter. Solid lines represent the best fits of normalized fluorescence decays to the ordered-sequential equation (eq 5). Results in panels A and B are summarized in Table 2. Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 7.0, and 25 °C.
Table 2.
Kinetic Parameters for Events Triggered by Divalent Cation Dissociation from the cPLA2-α C2 Domaina
| cation | treatment | cation dissociationb |
protein-to-membrane FRETc |
||
|---|---|---|---|---|---|
| k (s−1) | ΔFrel (%) |
k (s−1) | ΔFrel (%) |
||
| Ca2+ | without vesicles | 108 ± 2 | NAd | NAd | NAd |
| with vesicles | |||||
| step 1 | 2.5 ± 0.2 | 40 ± 2 | 3.1 ± 0.2 | 45 ± 2 | |
| step 2 | 0.41 ± 0.02 | 60 ± 2 | 0.54 ± 0.02 | 55 ± 2 | |
| Sr2+ | without vesicles | >560 ± 90e | NAd | NAd | NAd |
| with vesicles | |||||
| step 1 | 3.9 ± 0.3 | 65 ± 2 | 5.8 ± 0.6 | 68 ± 4 | |
| step 2 | 0.69 ± 0.07 | 35 ± 2 | 1.1 ± 0.3 | 32 ± 4 | |
| Ba2+ | without vesicles | >630 ± 160e | NAd | NAd | NAd |
| with vesicles | NDf | NDf | NDf | NDf | |
Determined by stopped-flow fluorescence spectroscopy as described in the legend of Figure 5, analyzed by fitting to a single-exponential equation (without vesicles) (eq 4) or to an ordered-sequential equation (with vesicles) (eq 5). Results expressed as averages ± SEM (n = 3). Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 7.0, and 25 °C.
Determined by monitoring the intrinsic Trp71 fluorescence of the C2 domain, as described in the legend of Figure 5A.
Determined by monitoring the decay of protein to membrane FRET, as described in the legend of Figure 5B.
Not applicable.
Value a lower limit estimate of k since a majority of the fluorescence change occurred during the dead time of the instrument.
Not determined.
To directly monitor the release of group IIA cations from the free C2 domain, EDTA was replaced with Quin-2, which also binds Sr2+ and Ba2+. At 25 °C, the fluorescence response of Quin-2 binding to these cations was too low to obtain an adequate fluorescence signal. However, at a reduced temperature (4 °C), the enhanced fluorescence signal of Quin-2 was sufficient to permit determination of rate constants (data not shown). As was the case at 25 °C, at 4 °C the rate constants for the release of Sr2+ (170 ± 20 s−1, n = 8) and Ba2+ (290 ± 70 s−1, n = 3) were still considerably greater than that for Ca2+ (14.5 ± 0.1 s−1, n = 3). These rate constants were independently confirmed by monitoring Trp71 emission upon chelation with EDTA (data not shown); at 4 °C, the rate constants for the release of Sr2+ (150 ± 20 s−1, n = 3) and Ba2+ (250 ± 20 s−1, n = 3) were also greater than that for Ca2+ (15.1 ± 0.1 s−1, n = 3). Together, these results indicate that Ca2+ dissociates ~10-fold more slowly from the free cPLA2-α C2 domain than do the larger Sr2+ and Ba2+ ions, and that the Trp71 fluorescence assay faithfully reports either the dissociation of metal ions or a very fast conformational change directly coupled to metal dissociation.
Cation release from the membrane-bound cPLA2-α C2 domain was also assessed by monitoring Trp71 fluorescence (Figure 5A and Table 2). Ca2+ release from the membrane-bound domain followed a sequential time course consisting of two steps (eq 5) with amplitudes representing 40 and 60% (steps 1 and 2, respectively) of the total fluorescence change (see ΔF values in Table 2). The two rate constants that were measured (2.5 and 0.41 s−1) were similar to those reported previously, which agree well with the sequential dissociation rate constants for two Ca2+ ions determined with Quin-2 (9). Similarly, Sr2+ release from the membrane-bound domain also followed a two-step process (Figure 5A). The rate constants for the two events (3.9 and 0.69 s−1) were each nearly 2-fold greater than those measured for Ca2+ and corresponded to 65 and 35% of the total fluorescence change, respectively. The rate constant for Ba2+ dissociation in the presence of PC membranes was not measured since little Ba2+-induced membrane binding was observed in equilibrium experiments (see Figure 4). Notably, although Ca2+ dissociates 2-fold more slowly than Sr2+ from the membrane-bound domain, this difference is not sufficient to explain the 9–20-fold greater efficacy of Ca2+ in driving the membrane docking reaction (Table 1).
The kinetics of C2 domain dissociation from the membrane were directly measured by monitoring the decay in protein-to-membrane FRET upon rapidly mixing a solution of the cPLA2-α C2 domain, 100 µM Ca2+ or Sr2+, and 95:5 PC/dPE membranes with a solution of EDTA (Figure 5B and Table 2). The FRET time courses were best-fitted with a biexponential equation representing a sequential dissociation process (eq 5). For Ca2+, the rate constants that were measured (3.1 and 0.54 s−1) were similar to those measured previously and agree well with the sequential dissociation rate constants for two Ca2+ ions and their accompanying changes in Trp71 emission (9). Both Sr2+ dissociation rate constants (5.8 and 1.1 s−1) were nearly 2-fold greater than those for Ca2+. These results indicate that, as previously observed for the Ca2+-occupied membrane-bound domain (9), the Sr2+-occupied membrane-bound domain loses one ion but remains docked to the membrane, and then loses the second ion during or shortly after membrane dissociation. Moreover, the higher membrane affinity of the Ca2+-loaded domain relative to that of the Sr2+-loaded domain stems at least partly from its 2-fold longer membrane-bound lifetime.
Binding of Representative Trivalent Cations
The ability of representative trivalent cations, including the lanthanide Lu3+, to bind to the cPLA2-α C2 domain and to induce docking to target membranes was tested at pH 6.0 due to the tendency to form insoluble hydroxides at higher pH values (Figure 6). Lu3+ bound to the C2 domain, as indicated by cation-induced changes in intrinsic Trp71 fluorescence, yielding an average (±SEM, n = 3) [Lu3+]1/2 value of 2.1 ± 0.4 µM and a Hill coefficient of 2.3 ± 0.2. Ca2+ also bound cooperatively to the cPLA2-α C2 domain under these conditions, yielding a Hill coefficient of 1.9 ± 0.2. However, the [Ca2+]1/2 value equal to 35 ± 2 µM observed at pH 6.0 was significantly greater than the value of 11 µM measured at pH 7.0 (Table 1). Similarly, Ca2+ also induced membrane docking under these conditions in the FRET assay (Figure 6B), yielding a Hill coefficient of 1.5 ± 0.1 and a [Ca2+]1/2 value of 16.6 ± 0.8 µM, which was also greater than the value of 2 µM measured at pH 7.0 (Table 1). Like Ca2+, Lu3+ induced docking of the C2 domain to PC membranes (Figure 6B), but the sub-micromolar apparent affinity of binding was too high to allow accurate determination of the [Lu3+]1/2 and Hill coefficient required for membrane docking. Other trivalent cations, including the group IIIB ion La3+ and the lanthanide ions Nd3+ and Gd3+, also bound to the cPLA2-α C2 domain and induced membrane docking at sub-micromolar concentrations (data not shown). These results indicate that trivalent cations can bind to the isolated cPLA2-α C2 domain with a stoichiometry of at least two, in some cases with higher affinity than Ca2+, and can functionally replace Ca2+ to induce membrane docking.
Figure 6.
Trivalent cations bind to the cPLA2-α C2 domain and induce membrane docking. (A) Intrinsic fluorescence changes in Trp71 of the C2 domain induced by Lu3+ (black symbols) or Ca2+ (white symbols) in the absence of membranes. Fluorescence emission of Trp71 was monitored (λem = 325 nm). The observed fluorescence change (ΔF) was normalized to the calculated maximal cation-induced fluorescence change (ΔFmax). Solid lines represent fitting to the Hill equation (eq 1). Results are summarized in the text. (B) Cation dependence of C2 domain docking to PC membranes containing dansyl-PE measured by protein to membrane FRET (λem = 520 nm). The observed FRET change (ΔF) in response to Lu3+ (black symbols) or Ca2+ (white symbols) was fitted (—) with the Hill equation (eq 2) and normalized to the calculated maximal cation-induced FRET change (ΔFmax). Results are summarized in the text. Experimental conditions: 100 mM KCl, 20 mM PIPES, pH 6.0, and 25 °C (λex = 284 nm).
DISCUSSION
These results demonstrate that a combination of cation charge and size constraints in the Ca2+-binding site shapes the strong Ca2+ selectivity of the cPLA2-α C2 domain. These constraints enable the domain to bind to mobilized Ca2+ generated during cellular activation while immersed in high cytoplasmic concentrations of other physiological cations. The fundamental principles underlying these constraints play an important role in shaping the cation affinity and selectivity not only of C2 domains but also of other Ca2+-binding proteins, including EF-hands, and of synthetic organic chelators (reviewed in refs 33 and 38). In contrast to the EF-hand and other Ca2+-binding motifs characterized to date, however, the two Ca2+ ions that bind with positive cooperativity to the C2 motif are located immediately adjacent to one another. In the cPLA2-α C2 domain, the center-to-center distance of the two Ca2+ ions is only 4.2 Å (6). These results suggest that two metal ions are essential for stable docking to target membranes. These conclusions likely can be generalized to other C2 domains, since similarities in divalent cation selectivity by different C2 domains have been noted (14–17, 39). The following discussion will focus on both the equilibrium and kinetic features of metal ion and membrane binding to the cPLA2-α C2 domain.
Cation Binding to the Free cPLA2-α C2 Domain
The kinetic scheme for divalent cation binding to the free cPLA2-α C2 domain is represented by a sequential, two-step mechanism originally proposed for Ca2+ binding (9): where steps 1 and 2 represent the sequential macroscopic binding of two metal ions (Me) to the free C2 domain. The order of metal ion binding is indicated by subscripts, where Me1 represents the first ion to bind and the last to dissociate, governed by forward and reverse rate constants k1 and k−1, respectively. Evidence that the cPLA2-α C2 domain binds Ca2+ with a stoichiometry of two ions per free domain has been provided by a variety of approaches (6–9), including the Hill coefficient of 1.8 obtained in this study. Similarly, the Hill coefficient of 1.4 measured in this study for Sr2+ binding to the free domain suggests a stoichiometry of two ions per domain, as detailed by the two steps in Scheme 1. By contrast, the measured Hill coefficient of 1.0 for Ba2+ suggests a stoichiometry of just one per domain for this ion, as indicated by the first step of Scheme 1. For both Ca2+ and Sr2+, the highly cooperative binding indicates that the C2•Me2 species is much more stable than C2•Me1 such that the latter does not accumulate to a great extent. Further evidence for this picture is provided by the observation that the irreversible dissociation of the two Ca2+ or Sr2+ ions upon rapid mixing with EDTA (or Quin-2) follows a monoexponential time course, indicating that the two ions dissociate virtually simultaneously in a cooperative manner to yield a single observable step: where kdiss represents the observed rate constant for dissociation. In reality, this dissociation must consist of two steps such that the second step is too fast to detect: where, as above, k−2 and k−1 represent the dissociation rate constants of the Me2 and Me1 ions, respectively. In the framework of the sequential binding model (Scheme 1), this two-step process simplifies to a single observable step (Scheme 1a) when k−1 ≫ k−2, i.e., when the C2•Me1 species is much less stable than the C2•Me2 species such that dissociation of Me2 is rate-limiting.
Scheme 1.

Scheme 1a.

Cation Charge Selectivity of the Free C2 Domain
Comparison of the binding of representative group IA, IIA, and lanthanide cations to the cPLA2-α C2 domain reveals striking charge selectivity of the free domain. The monovalent cations K+ and Na+ both fail to induce environmental changes in the C2 domain that increase Trp71 emission, fail to induce mobility shifts in the C2 domain subjected to native PAGE, and fail to protect the C2 domain against thermal denaturation, suggesting they are excluded from the C2 domain Ca2+-binding site at concentrations as high as 100–200 mM. In contrast, each of the group IIA cations and representative trivalent cations was able to bind to the C2 domain with millimolar or greater affinity as judged by at least one of these biochemical criteria. K+ and Na+, whose effective ionic radii (EIR) are 1.12 and 1.46 Å for 7-fold coordination (33), respectively, are similar in size to Ca2+ and Ba2+ whose EIR are 1.06 and 1.38 Å, respectively. The failure of the former monovalent cations to bind to the free C2 domain (step 1, Schemes 1–3) is proposed to arise from their lack of sufficient charge for stabilizing the close packing of coordinating protein oxygens that must occur as the cation binds to the metal binding cleft of the C2 domain. Sufficient negative charge density is present on these oxygens for accommodation of the binding of two divalent or trivalent cations as indicated by the Hill coefficients for Ca2+, Sr2+, and Lu3+. The higher charge densities of divalent and trivalent cations are able to overcome the considerable electrostatic repulsion between coordinating oxygens as they pack around the bound metal ions. This “electrostatic repulsion” model of charge selectivity by the cPLA2-α C2 domain is illustrated in Figure 7.
Scheme 3.
Figure 7.
Electrostatic repulsion and size exclusion models of cation selectivity proposed for the cPLA2-α C2 domain. Representation of the Ca2+-binding site of the cPLA2-α C2 domain (6), where coordinating oxygens are represented by solid red spheres and dot surfaces indicate three ordered water molecules occupying the solvent-exposed coordination positions of the bound Ca2+ ions (yellow spheres). The following events are proposed to occur prior to and during cation-triggered membrane docking. In the absence of bound cations, electrostatic repulsion (arrows pointing outward) between oxygens in the site destabilizes the CBLs which as a result are relatively dynamic. Unlike monovalent cations, di- and trivalent spherical cations are able to bind to the site, overcoming this repulsion and immobilizing the CBLs. The first multivalent ion binds at site II, and then the second binds at site I. Binding of Mg2+ in site II is relatively unfavorable because the compression of the site to accommodate this small ion is opposed by the repulsion between the coordinating oxygens, and because dehydration of this small ion is energetically costly. At the other end of the size selectivity spectrum, a second Ba2+ ion fails to bind because the large Ba2+ ion in site II overlaps or distorts the coordinating oxygen array in site I. When multivalent cations of acceptable size are bound, favorable electrostatic contacts between the cations and coordinating oxygens (arrows pointing inward) stabilize the CBLs in the conformation appropriate for membrane docking. Cations whose radii are too large for the site are excluded by the forces of steric strain (again, arrows pointing inward) which restrict the volume available for ion binding. When two multivalent cations of acceptable size occupy the site, hydrophobic groups on the CBLs are properly positioned for insertion into the hydrocarbon phase of the lipid bilayer. Subsequent membrane docking replaces the indicated water molecules with coordinating phospholipid oxygens.
Divalent Cation Size Selectivity of the Free C2 Domain
Each of the group IIA cations is able to bind to the free cPLA2-α C2 domain in solution. However, these divalent cations differ markedly in potency and in the metal stoichiometry that can be achieved in the micromolar range. Although Mg2+ concentrations of >1 mM induce an increase in Trp71 emission, 1 mM Mg2+ fails to induce the electrophoretic mobility shift and to stabilize the domain against thermal denaturation. By contrast, the larger divalent cations Ca2+, Sr2+, and Ba2+ each bind to the free C2 domain with low micromolar affinity. The [Ca2+]1/2 value for binding to the isolated cPLA2-α C2 domain based on Trp71 fluorescence is only 3-fold lower than the [Sr2+]1/2 value and is essentially identical to the [Ba2+]1/2 value, suggesting that the C2 domain binds at least one ion of Ca2+, Sr2+, and Ba2+ with roughly similar affinities. These results indicate that for divalent cations with effective ionic radii exceeding 0.8 Å, the EIR of Mg2+, at least one ion can bind to the site with little size selectivity in the absence of membranes (step 1, Schemes 1–3).
As noted above, among the group IIA cations, only Ca2+ and Sr2+ appear to achieve a stoichiometry of two in the micromolar range in the absence of membranes, suggesting that only these ions can fill the second metal ion site efficiently (step 2, Scheme 1). Indeed, in the absence or presence of membranes, the Ba2+ fluorescence titration data (Figure 4D) are well-approximated by saturable binding to a single, independent site with a dissociation constant of 15 ± 2 µM (data not shown). Thus, in the micromolar range, the size of the cation-binding site of the free cPLA2-α C2 domain is restricted to exclude even a single Mg2+ ion, is restricted to include only one Ba2+ ion, but easily accommodates two Ca2+ or Sr2+ ions. The effective ionic radii of these ions for 7-fold coordination are 0.8 Å (Mg2+), 1.06 Å (Ca2+), 1.21 Å (Sr2+), and 1.38 Å (Ba2+) (33). These results indicate that the optimal radius for the second ion is approximately 1.1 Å and that ions with radii much greater than 1.2 Å are excluded (step 2, Scheme 1). The exclusion of the physiological ion Mg2+ not only arises from its small size, which is presumed to prevent optimal contacts with the coordinating oxygen array, but also must stem in part from its large free energy of dehydration (33). This “size exclusion” model of divalent cation selectivity is illustrated in Figure 7. The nearly total exclusion of the second Ba2+ ion arises only from its large size, which is presumed to exceed the volume capacity of the coordinating oxygen array already occupied by one large Ba2+ ion. Comparison of the dissociation time courses of Ca2+, Sr2+, and Ba2+ provides insights into the relationship between dissociation kinetics and ionic size. As noted above, the rate constant for dissociation of Me2 limits the dissociation of Me1 (k−2 ≪ k−1, Scheme 1b) so that monoexponential time courses are observed even when two divalent cations dissociate (Scheme 1a). Since the observed dissociation rate constant is larger for Sr2+ than for Ca2+ (Table 2), the k−2 value for the Me2 ion appears to increase with increasing divalent cation size. Moreover, the very rapid dissociation of Ba2+ relative to that of Ca2+ and Sr2+ is likely to reflect the very large dissociation rate constants (k−1) of Me1 ions bound to the site in the absence of Me2.
Scheme 1b.

Overall, the current working model for the interaction of two medium-sized divalent cations with the free C2 domain proposes that the Me1 ion first binds weakly and organizes the site to increase the affinity for the Me2 ion, which subsequently binds and stabilizes the fully occupied site. Subsequently, when the Me2 ion dissociates, the Me1 ion follows rapidly due to its lower affinity. The positive cooperativity observed for the binding of Lu3+ ions to the free domain suggests that the same model applies to this trivalent lanthanide ion.
Kinetic Scheme for the Binding of Two Multivalent Cations and Subsequent Membrane Docking
A three-step kinetic scheme is required to describe the metal ion-induced docking of the cPLA2-α C2 domain to phospholipid membranes (PL): where steps 1 and 2 represent the sequential binding of two medium-sized divalent or trivalent cations to the free C2 domain and are identical to those in Scheme 1. Step 3 represents the formation of the high-affinity domain–membrane ternary complex (C2•Me1•Me2•PL) with forward and reverse rate constants of k3 and k−3, respectively. Evidence that two multivalent cations ions bind cooperatively to the free C2 domain prior to membrane docking is discussed above; moreover, Ca2+ and Sr2+ each exhibit biexponential kinetics when dissociating from the membrane-bound complex, confirming that two ions remain bound to the domain when docked to the membrane. These findings reinforce the previous direct stoichiometry measurement of two ions per membrane-bound domain for Ca2+ (9).
In principle, one must also consider other kinetic schemes for metal-stabilized membrane docking in which one or both metal ions can bind after the unsaturated domain is weakly bound to the membrane. In fact, the slow biexponential dissociation of two Ca2+ or Sr2+ ions from the membrane-bound domain indicates that one ion leaves before the domain fully dissociates from the membrane, supporting the idea that a domain occupied by a single divalent cation can be weakly membrane-bound. Therefore, an alternative pathway for metal ion-induced docking of the cPLA2-α C2 domain to phospholipid membranes could be proposed: where rate constants for steps 2 and 3 are not identical to those depicted in Scheme 2. Whether C2•Me1 first binds Me2 before binding membranes (k2, Scheme 2) or first binds PL before binding Me2 (k2, Scheme 3) depends on the relative rates of these two competing steps, which in turn depend on the rate constants of the steps and the concentrations of metal ions and membranes. In general, Scheme 2 is expected to dominate for metal ions such as Ca2+, Sr2+, and Lu3+ that exhibit strong positive cooperativity in binding to the free domain, since for these metals the concentration of C2•Me1 will generally be much lower than that of C2•Me2. This picture is further supported by the observation that the domain saturated with a single bound divalent cation at micromolar Ba2+ concentrations exhibits little membrane affinity, while much higher Ba2+ concentrations yield weak membrane docking presumably by driving the binding of a second Ba2+ ion (Table 1 and Figure 4A).
Scheme 2.
Overall, the evidence strongly suggests that two multivalent cations bind to the free domain prior to membrane docking, and that no additional ions are bound after docking. Moreover, the relative affinities observed for binding of two multivalent ions to the free domain are similar to the relative potencies of these ions when used to drive membrane docking (in both cases, Lu3+ > Ca2+, Sr2+ ≫ Mg2+, Ba2+). It follows that the free domain largely controls metal binding stoichiometry and selectivity, which is established prior to the membrane docking event. Minor additional modulation of selectivity is provided by the protein–membrane interaction, since the ratio of Ca2+ to Sr2+ affinities increases 2-fold in the presence of membranes.
Different Membrane Affinities of the Domain Loaded with Two Cations
Even in the presence of saturating concentrations of divalent cations, the Ca2+-loaded C2 domain binds to PC membranes with 4-fold higher affinity than the Sr2+-loaded C2 domain, due at least in part to the longer membrane-bound lifetime of the Ca2+-loaded domain. This membrane affinity difference likely arises from the fact that the metal-binding loops of the cPLA2-α C2 domain interact directly with the membrane surface (7, 24, 36). The different membrane affinities of the ion-saturated domain suggest that either (i) the protein-bound metal ions themselves directly contact the membrane, thereby modulating the nature of the protein–membrane interaction, or (ii) the conformations of the membrane-docked Ca2+ binding loops differ when occupied with various divalent cations. The former possibility is consistent with the observation that Ca2+ bound to the isolated C2 domain is partially exposed to solvent, where coordinating water molecules could be displaced by head-group oxygens upon docking to a phospholipid bilayer. Moreover, direct headgroup coordination of the protein-bound Ca2+ ions has been observed in the crystal structure of the complex between the PKC-α C2 domain and a short chain lipid (21). The latter possibility is consistent with the presence of numerous hydrophobic residues of the cPLA2-α Ca2+-binding loops that are exposed to solution such that conformational rearrangements of these loops could occur upon membrane docking. These possibilities are widely relevant to Ca2+-dependent membrane-binding C2 domains, which all appear to contact membranes through their Ca2+-binding loops (discussed in ref 12).
Comparison to Other C2 Domains
The C2 domain Ca2+-binding site binds multiple Ca2+ ions in a positively cooperative manner, thus enabling the domain to respond to small changes in intracellular Ca2+ concentrations, a feature exhibited by many Ca2+-binding signaling proteins (33, 38). Four distinct sites appear to be occupied to varying extents in different C2 domains. Sites II–IV are utilized in the Syt- IA and PKC-β C2 domains; sites I–III are utilized in phospholipase C-δ1 (PLC-δ1), whereas only sites I and II are occupied in cPLA2-α (4) (see Figure 7). We hypothesize that in the cPLA2-α C2 domain and all other C2 domains, Ca2+ binds first to site II (step 1, Schemes 1–3), since (i) this site is the sole site occupied in crystals of the synaptotagmin C2A domain (3), (ii) NMR studies have indicated that this site fills first in the Syt-IA and PKC-β C2 domain (5, 40, 41), (iii) the coordinating ligands in this site, but not others, are strictly conserved throughout Ca2+-dependent C2 domains (1), and (iv) binding measurements have indicated remarkably similar affinities (~20–60 µM) for the binding of the first Ca2+ ion to each of the cPLA2-α, PKC-β, and Syt-IA C2 domains in the absence of membranes (12, 19, 40, 41). Upon occupation of the first Ca2+ ion in site II, the occupancy at other sites depends on the given C2 domain. For cPLA2-α, only site I is occupied by the second Ca2+ ion (step 2, Schemes 1 and 2, and step 3, Scheme 3), since sites III and IV are inactivated by substitution of Asn for Asp (at position 95) and Val for Ser (at position 97), respectively. For PLC-δ1, both sites I and III are occupied after site II. In Syt-IA and PKC-β, site I is inactivated due to substitution of a Lys for Asn (corresponding to Asn-65 in cPLA2-α) in the second Ca2+-binding loop; thus, sites III and IV are filled after site II. On the basis of the sequence alignment of the C2 domain (1), most other C2 domains that have been reported to bind phospholipid membranes in a Ca2+-dependent manner are predicted to coordinate Ca2+ in a fashion similar to that of the PKC-β and Syt-IA C2 domains.
Mechanism of Ca2+-Triggered Membrane Docking
Figure 7 illustrates a model for the mechanism of Ca2+-triggered membrane docking that incorporates the results presented here. In the apo state of the C2 domain, the strong electrostatic repulsion between the coordinating oxygens concentrated in the Ca2+-binding cleft destabilizes the loops and increases their inherent flexibility. Greater flexibility is supported by the lower thermal stability of the domain in the absence of bound cations (present report and refs 34 and 35), a considerable increase in average temperature factors in loop regions in the crystal structures of apo-C2 domains (42), and greater flexibility in the loops of the apo-C2 domain of the Syt-IA C2 domain observed by NMR spectroscopy (5). Monovalent ions are excluded because their lower charge density is unable to overcome the strong electrostatic repulsion of the coordinating oxygens when they closely pack around the metal. Mg2+ is excluded because it is too small for the coordination cavity, preventing the optimal metal–oxygen contacts, and due to its greater dehydration free energy. The first Ca2+, Sr2+, Ba2+, or Lu3+ ion binds to site II with relatively low affinity because of the inherent flexibility of the metal-binding loops in the apo state. The binding of this first multivalent cation organizes the site by partially neutralizing the negative charge in the site and thus constraining the flexible loops. The partial stabilization of the loops by cation binding constitutes initiation of the “conformational change” that induces environmental changes transmitted to Trp71 in the cPLA2-α C2 domain, ~12 Å from the Ca2+-binding cleft. A second identical Ca2+, Sr2+, or Lu3+ ion binds to site I immediately adjacent to the first ion (approximately 4 Å away, center-to-center distance) in a positively cooperative manner due to the favorable preorientation of ligand oxygens that coordinate it. For Ba2+, the binding of the first ion partially stabilizes the C2 domain as measured by increased thermal stability and environmental changes transmitted to the environment of the buried Trp71. However, this larger Ba2+ ion occludes or distorts the second site, yielding half-occupancy.
Membrane docking is triggered by the occupancy of the cleft with two multivalent cations, which alter the local electrostatics, immobilize the loops, and create a stable membrane docking surface composed of the Ca2+-binding loops and the metal ions themselves. The two bound ions are occluded in the C2 domain–membrane complex, either by steric blockage of the pathway for metal ion dissociation or by direct metal ion coordination by oxygens of the phospholipid headgroup. The C2 domain binds to the membrane surface through variable portions of the Ca2+-binding loops (reviewed in ref 36). For the cPLA2-α C2 domain, several hydrophobic side chains are oriented favorably for interactions with membranes, highlighting the importance of hydrophobic interactions between this C2 domain and PC membranes (reviewed in ref 12). For other C2 domains such as those in PKC-β and Syt-IA, a substantial decrease in negative surface potential favors interactions with anionic phospholipids (reviewed in ref 12).
Comparison to Other Divalent Cation Binding Proteins
Overall, the divalent cation size selectivity of the cPLA2-α C2 domain is novel, being intermediate between those of nonselective Mg2+-binding sites such as that of the CheY protein and strongly selective Ca2+-binding sites such as those of certain EF-hand proteins. The weak size selectivity of the CheY Mg2+-binding site has been proposed to stem from the surface location of its cluster of coordinating carboxylates where there are few constraints on cavity size and coordination number (31). Since the coordination of divalent cation is completed by water molecules, larger cations can simply employ more coordinating water molecules as needed (31). By contrast, the most strongly selective EF-hand sites completely surround the coordinated cation with seven oxygen ligands originating from protein side chains and backbone carbonyl groups, providing a fixed cavity size and coordination number (33, 38). The size selectivity of the C2 domain exhibits features of both prototypical metal binding sites. Mg2+ ions are excluded, as in the EF-hand motif, whereas the first binding event shows little discrimination between Ca2+, Sr2+, and Ba2+, as in the CheY site. It follows that the ion binding cavity of the first C2 domain site cannot be configured to provide the 6-fold coordination preferred by Mg2+, but does allow for adequate coordination for metals the size of Ca2+ and larger.
Conclusion
Cation charge and size constraints ensure that the cPLA2-α C2 domain can act as a Ca2+-regulated “on–off” switch for membrane targeting in a physiological setting. The capacity of the domain to bind two multivalent cations of the appropriate size is governed primarily by the C2 domain itself rather than by the target membrane, since the free domain selectively binds only certain multivalent cations with a stoichiometry of two, and this same selectivity is observed in cation-triggered membrane docking. The physical origins of the ionic charge and size constraints will require further investigation to determine the contribution of individual residues in shaping the ion selectivity and affinity of the C2 domain Ca2+-binding site. Potentially, cation size and charge constraints also shape the Ca2+ selectivity and affinity in other C2 domains, where they are likely to vary considerably given reported differences in Ca2+ binding stoichiometry, affinity, cooperativity, and kinetics. These varying constraints are likely to have arisen from the functional specialization of different C2 domains which leads to the expansion of the repertoire of signaling roles carried out by C2 domain proteins (12).
Footnotes
Support provided by NIH Grant GM R01-63235 (J.J.F.) and NIH Postdoctoral Fellowship GM-18303 (E.A.N.).
Abbreviations: Syt-IA, synaptotagmin I-A; cPLA2-α, cytosolic phospholipase A2 α; PKC-β, protein kinase C β; PC, phosphatidylcholine; PAGE, polyacrylamide gel electrophoresis; EDTA, ethylene-diaminetetraacetic acid; PIPES, piperazine-N,N′-bis(2-ethanesulfonic acid); FRET, fluorescence resonance energy transfer; dansyl-PE or dPE, N-[5-(dimethylamino)naphthalene-1-sulfonyl]-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine; EIR, effective ionic radius; PLC-δ1, phospholipase C δ1; SEM, standard error of the mean.
REFERENCES
- 1.Nalefski EA, Falke JJ. Protein Sci. 1996;5:2375–2390. doi: 10.1002/pro.5560051201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rizo J, Südhof TC. J. Biol. Chem. 1998;273:15879–15882. doi: 10.1074/jbc.273.26.15879. [DOI] [PubMed] [Google Scholar]
- 3.Sutton RB, Davletov BA, Berghuis AM, Südhof TC, Sprang SR. Cell. 1995;80:929–938. doi: 10.1016/0092-8674(95)90296-1. [DOI] [PubMed] [Google Scholar]
- 4.Sutton RB, Sprang SR. Structure. 1998;6:1395–1405. doi: 10.1016/s0969-2126(98)00139-7. [DOI] [PubMed] [Google Scholar]
- 5.Shao X, Fernandez I, Südhof TC, Rizo J. Biochemistry. 1998;37:16106–16115. doi: 10.1021/bi981789h. [DOI] [PubMed] [Google Scholar]
- 6.Perisic O, Fong S, Lynch DE, Bycroft M, Williams RL. J. Biol. Chem. 1998;273:1596–1604. doi: 10.1074/jbc.273.3.1596. [DOI] [PubMed] [Google Scholar]
- 7.Xu GY, McDonagh T, Yu HA, Nalefski EA, Clark JD, Cumming DA. J. Mol. Biol. 1998;280:485–500. doi: 10.1006/jmbi.1998.1874. [DOI] [PubMed] [Google Scholar]
- 8.Dessen A, Tang J, Schmidt H, Stahl M, Clark JD, Seehra J, Somers WS. Cell. 1999;97:349–360. doi: 10.1016/s0092-8674(00)80744-8. [DOI] [PubMed] [Google Scholar]
- 9.Nalefski EA, Slazas MM, Falke JJ. Biochemistry. 1997;36:12011–12018. doi: 10.1021/bi9717340. [DOI] [PubMed] [Google Scholar]
- 10.Nalefski EA, Sultzman LA, Martin DM, Kriz RW, Towler PS, Knopf JL, Clark JD. J. Biol. Chem. 1994;269:18239–18249. [PubMed] [Google Scholar]
- 11.Nalefski EA, McDonagh T, Somers W, Seehra J, Falke JJ, Clark JD. J. Biol. Chem. 1998;273:1365–1372. doi: 10.1074/jbc.273.3.1365. [DOI] [PubMed] [Google Scholar]
- 12.Nalefski EA, Wisner MA, Chen JZ, Sprang SR, Fukuda M, Mikoshiba K, Falke JJ. Biochemistry. 2001;40:3089–3100. doi: 10.1021/bi001968a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular Biology of the Cell. 3rd ed. New York: Garland Publishing, Inc; 1994. [Google Scholar]
- 14.Davletov BA, Südhof TC. J. Biol. Chem. 1993;268:26386–26390. [PubMed] [Google Scholar]
- 15.Fukuda M, Kojima T, Mikoshiba K. Biochem. J. 1997;323:421–425. doi: 10.1042/bj3230421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Davletov BA, Südhof TC. J. Biol. Chem. 1994;269:28547–28550. [PubMed] [Google Scholar]
- 17.Li C, Davletov BA, Südhof TC. J. Biol. Chem. 1995;270:24898–24902. doi: 10.1074/jbc.270.42.24898. [DOI] [PubMed] [Google Scholar]
- 18.Reynolds LJ, Hughes LL, Louis AI, Kramer RM, Dennis EA. Biochim. Biophys. Acta. 1993;1167:272–280. doi: 10.1016/0005-2760(93)90229-3. [DOI] [PubMed] [Google Scholar]
- 19.Davis AF, Bai J, Fasshauer D, Wolowick MJ, Lewis JL, Chapman ER. Neuron. 1999;24:363–376. doi: 10.1016/s0896-6273(00)80850-8. [DOI] [PubMed] [Google Scholar]
- 20.Tocanne JF, Teissie J. Biochim. Biophys. Acta. 1990;1031:111–142. doi: 10.1016/0304-4157(90)90005-w. [DOI] [PubMed] [Google Scholar]
- 21.Verdaguer N, Corbalan-Garcia S, Ochoa WF, Fita I, Gomez-Fernandez JC. EMBO J. 1999;18:6329–6338. doi: 10.1093/emboj/18.22.6329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL. Cell. 1991;65:1043–1051. doi: 10.1016/0092-8674(91)90556-e. [DOI] [PubMed] [Google Scholar]
- 23.Evans JH, Spencer DM, Zweifach A, Leslie CC. J. Biol. Chem. 2001;276:30150–30160. doi: 10.1074/jbc.M100943200. [DOI] [PubMed] [Google Scholar]
- 24.Perisic O, Paterson HF, Mosedale G, Lara-Gonzalez S, Williams RL. J. Biol. Chem. 1999;274:14979–14987. doi: 10.1074/jbc.274.21.14979. [DOI] [PubMed] [Google Scholar]
- 25.Clark JD, Schievella AR, Nalefski EA, Lin LL. J. Lipid Mediators Cell Signalling. 1995;12:83–117. doi: 10.1016/0929-7855(95)00012-f. [DOI] [PubMed] [Google Scholar]
- 26.Kramer RM, Sharp JD. FEBS Lett. 1997;410:49–53. doi: 10.1016/s0014-5793(97)00322-0. [DOI] [PubMed] [Google Scholar]
- 27.Gijon MA, Leslie CC. J. Leukocyte Biol. 1999;65:330–336. doi: 10.1002/jlb.65.3.330. [DOI] [PubMed] [Google Scholar]
- 28.Kotake S, Hey P, Mirmira RG, Copeland RA. Arch. Biochem. Biophys. 1991;285:126–133. doi: 10.1016/0003-9861(91)90338-j. [DOI] [PubMed] [Google Scholar]
- 29.Nalefski EA, Falke JJ. In: Methods in Molecular Biology: Calcium-Binding Protein Protocols. Chapter 19. Vogel HJ, editor. Vol. 1. Totowa, NJ: Humana Press; 2001. [Google Scholar]
- 30.Grabarek Z, Gergely J. J. Biol. Chem. 1983;258:14103–14105. [PubMed] [Google Scholar]
- 31.Needham JV, Chen TY, Falke JJ. Biochemistry. 1993;32:3363–3367. doi: 10.1021/bi00064a020. [DOI] [PubMed] [Google Scholar]
- 32.Tonomura B, Nakatani H, Ohnishi M, Yamaguchi-Ito J, Hiromi K. Anal. Biochem. 1978;84:370–383. doi: 10.1016/0003-2697(78)90054-4. [DOI] [PubMed] [Google Scholar]
- 33.Falke JJ, Drake SK, Hazard AL, Peersen OB. Q. Rev. Biophys. 1994;27:219–290. doi: 10.1017/s0033583500003012. [DOI] [PubMed] [Google Scholar]
- 34.Shao X, Li C, Fernandez I, Zhang X, Südhof TC, Rizo J. Neuron. 1997;18:133–142. doi: 10.1016/s0896-6273(01)80052-0. [DOI] [PubMed] [Google Scholar]
- 35.Garcia-Garcia J, Corbalan-Garcia S, Gomez-Fernandez JC. Biochemistry. 1999;38:9667–9675. doi: 10.1021/bi9905765. [DOI] [PubMed] [Google Scholar]
- 36.Nalefski EA, Falke JJ. Biochemistry. 1998;37:17642–17650. doi: 10.1021/bi982372e. [DOI] [PubMed] [Google Scholar]
- 37.Wu P, Brand L. Anal. Biochem. 1994;218:1–13. doi: 10.1006/abio.1994.1134. [DOI] [PubMed] [Google Scholar]
- 38.Linse S, Forsen S. Adv. Second Messenger Phosphoprotein Res. 1995;30:89–151. doi: 10.1016/s1040-7952(05)80005-9. [DOI] [PubMed] [Google Scholar]
- 39.Sugita S, Hata Y, Südhof TC. J. Biol. Chem. 1996;271:1262–1265. doi: 10.1074/jbc.271.3.1262. [DOI] [PubMed] [Google Scholar]
- 40.Shao X, Davletov BA, Sutton RB, Südhof TC, Rizo J. Science. 1996;273:248–251. doi: 10.1126/science.273.5272.248. [DOI] [PubMed] [Google Scholar]
- 41.Ubach J, Zhang X, Shao X, Südhof TC, Rizo J. EMBO J. 1998;17:3921–3930. doi: 10.1093/emboj/17.14.3921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Essen LO, Perisic O, Lynch DE, Katan M, Williams RL. Biochemistry. 1997;36:2753–2762. doi: 10.1021/bi962466t. [DOI] [PubMed] [Google Scholar]









